Serum bactericidal activity of levofloxacin against Streptococcus pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue SUPPL. C, 1999, Pages 61-65

  Shah, P M ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; LEVOFLOXACIN; PENICILLIN G;

ADULT; ANTIBIOTIC SENSITIVITY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CULTURE MEDIUM; DILUTION; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; SERUM BACTERICIDAL ACTIVITY; STREPTOCOCCUS PNEUMONIAE;

EID: 0033013137     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.suppl_3.61     Document Type: Conference Paper

References (18)

1. Schlichter, J. G. & MacLean, H. (1974). A method of determining the effective therapeutic level in the treatment of subacute bacterial endocarditis with penicillin: a preliminary report. American Heart Journal 34, 209-11.
2. Weinstein, M. P., Stratton, C. W., Ackley, A., Hawley, H. B., Robinson, P. A., Fisher, B. D. et al. (1985). Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis. American Journal of Medicine 78, 262-9.
3. Weinstein, M. P., Stratton, C. W., Hawley, H. B., Ackley, A. & Reller, L. B. (1987). Multicenter collaborative evaluation of a standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis. American Journal of Medicine 83, 218-22.
4. Yamane, N., Jones, R. N., Frei, R., Hoban, D. J., Pignatari, A. C. & Marco, F. (1994). Levofloxacin in vitro activity: results from an international comparative study with ofloxacin and ciprofloxacin. Journal of Chemotherapy 6, 83-91.
5. Frémaux, A., Sissia, G., Bryskier, A. & Geslin, P. (1995). Comparative in vitro activity of levofloxacin and five other fluoroquinolones against ofloxacin-resistant and ofloxacin-susceptible Streptococcus pneumoniae. In Program and Abstracts of the Seventh European Congress of Clinical Microbiology and Infectious Diseases, Vienna, 1995. Abstract 305. The European Society of Clinical Microbiology and Infectious Diseases.
6. Davis, R. & Bryson, H. M. (1994). Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs 47, 677-700.
7. Fish, D. N. & Chow, A. T. (1997). The clinical pharmacokinetics of levofloxacin. Clinical Pharmacokinetics 32, 101-19.
8. Markus, A., Isert, D., Klesel, N. & Seibert, G. (1995). Killing activity of levofloxacin (LEV) and ciprofloxacin (CIP) against Streptococcus pneumoniae in vitro and in vivo. In Program and Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract E30, p. 90. American Society for Microbiology, Washington DC.
9. Barry, A. L., Fuchs, P. C., Allen, S. D., Brown, S. D., Jorgensen, J. H. & Tenover, F. C. (1996). In-vitro susceptibility of Streptococcus pneumoniae to the D-and L-isomers of ofloxacin: interpretive criteria and quality control limits. Journal of Antimicrobial Chemotherapy 37, 365-9.
10. Frémaux, A., Sissia, G. & Geslin, P. (1999). In-vitro bacteriostatic activity of levofloxacin and three other fluoroquinolones against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 43, Suppl. C, 9-14.
11. Echols, R., Weinstein, M. P., O'Keeffe, B., Shah, A. & Heller, A. H. (1994). Comparative crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin and ofloxacin. Journal of Antimicrobial Chemotherapy 33, 111-8.
12. National Committee for Clinical Laboratory Standards. (1992). Methodology for the Serum Bactericidal Test: Tentative Guideline M21-T. NCCLS, Wayne, PA.
13. Machka, K. & Milatovic, D. (1987). Serum bactericidal activity of ciprofloxacin and ofloxacin in volunteers. European Journal of Clinical Microbiology 6, 59-62.
14. Boeckh, M., Lode, H., Deppermann, K.-M., Grineisen, S., Shokry, F., Held, R. et al. (1990). Pharmacokinetics and serum bactericidal activities of quinolones in combination with clindamycin, metronidazole, and ornidazole. Antimicrobial Agents and Chemotherapy 34, 2407-14.
15. Trautmann, M., Krause, B., Birnbaum, D., Wagner, J. & Lenk, V. (1986). Serum bactericidal activity of two newer quinolones against Salmonella typhi compared with standard therapeutic regimens. European Journal of Clinical Microbiology 5, 297-302.
16. Trautmann, M., Ruhnke, M., Borner, K., Wagner, J. & Koeppe, P. (1995). Pharmacokinetics of sparfloxacin and serum bactericidal activity against pneumococci. In Program and Abstracts of the Seventh European Congress of Clinical Microbiology and Infectious Diseases, Vienna, 1995. Abstract 717. The European Society of Clinical Microbiology and Infectious Diseases.
17. Muller-Serieys, C., Decré, D., Benoit, C., Maubert, B. & Carbon, C. (1999). Levofloxacin: serum bactericidal activity against methicillin-resistant S. aureus isolates. Journal of Antimicrobial Chemotherapy 43, Suppl. C, 67-70.
18. Wiedersich, A., Geerdes-Fenge, H. F., Rau, M., Wagner, S., Bryskier, A. & Lode, H. (1997). Serum bactericidal activity of levofloxacin. In Program and Abstracts of the Eighth European Congress of Clinical Microbiology and Infectious Diseases, Lausanne, 1997. Abstract P378. Clinical Microbiology and Infection 3, Suppl. 2, 84.